Cambridge Biolabs

A great gathering of companies at different levels with healthcare related technologies in molecular and cellular biology.
Created by Dr. Johannes Fruehauf in 2009, Cambridge Biolabs is deeply routed in the local biotech network and a member of MassBio.

"The hit-the-ground-running, local, contract research organization serving the Boston Innovation Supercluster in Kendall Square"

"Cambridge Biolabs clients are start-up biotechnology companies and venture capitalists who need their scientists to get started producing results immediately." | Cambridge Biolabs website

- more content to come soon -

Cambridge Biolabs have a wet bench lab space for molecular, cellular biology and microbiology. They also have a cell culture suite and numerous regional partnerships for in vivo work.

They are specialized in:

  • Drug delivery
  • Drug development
  • Oncology
  • Immunology
  • RNAi therapeutics
  • Stem cell therapeutics
  • Gastrointestinal diseases.
  • RaNA Therapeutics

  • Based on a technology to selectively activate target genes using non-coding RNA
  • Recently raised 20.7 M$
  • Vedantra Pharmaceuticals

  • A spin-out from the laboratory of Prof. Darrell Irvine at MIT, based on a technology for targeted drug delivery using lipid nanoparticules
  • No date restriction, contact them directly:

    One Kendall Square
    Suite 2203, Bldg 200
    Cambridge, MA 02139

    Check their website to know more

    Comments are closed.